Free Trial
→ White House to reset Social Security? (From Altimetry) (Ad) Buy RCKTW Stock  Free RCKTW Stock Alerts

Rocket Pharmaceuticals (RCKTW) SEC Filings & 10K Form

Rocket Pharmaceuticals logo
$0.04 -0.01 (-19.31%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Rocket Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
05/20/2025
2:13 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:15 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:17 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Schwartz Jonathan David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:21 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:29 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:32 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:18 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
8:59 AM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/07/2025
9:02 AM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
04/30/2025
3:14 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form DEF 14A
04/30/2025
3:15 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form DEFA14A
04/30/2025
3:16 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form ARS
04/22/2025
2:17 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/14/2025
5:57 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
4:10 PM		MAVERICK CAPITAL LTD (Filed by)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form SCHEDULE 13G
04/10/2025
3:07 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
2:26 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2025
3:06 PM		Ondrey Aaron (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:24 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
2:25 PM		Ondrey Aaron (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:01 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Schwartz Jonathan David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:01 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
11:56 AM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Schwartz Jonathan David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:29 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:09 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:11 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:11 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
9:25 AM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/05/2025
6:47 PM		Pratumsuwan Piratip (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:43 PM		Pratumsuwan Piratip (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2025
2:15 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
8:28 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
2:33 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
6:38 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
RTW INVESTMENTS, LP (Reporting)
WONG RODERICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:51 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13D/A
12/12/2024
5:02 AM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 424B5
11/25/2024
3:05 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:26 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Do You Believe In President Trump? Answer This 1 Question (Ad)

They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.

Protect your savings without betraying Trump
11/21/2024
3:06 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
2:58 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
2:27 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
3:15 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
9:52 AM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
3:45 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
2:24 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
2:34 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
4:05 PM		Bjork Elisabeth (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:07 PM		Dolsten Mikael (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:05 PM		Dolsten Mikael (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2024
3:06 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:26 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
2:29 PM		Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:39 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:16 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:23 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
3:15 PM		ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
3:05 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
2:22 PM		Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:05 PM		ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
White Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
2:17 PM		ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
9:34 AM		Makker Gotham (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RCKTW) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
The one deadline Elon can't afford to miss...
For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...
Brownstone Research | Sponsored
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...
Stansberry Research | Sponsored